Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.
Veronesi U, Mariani L, Decensi A, Formelli F, Camerini T, Miceli R, Di Mauro MG, Costa A, Marubini E, Sporn MB, De Palo G.
Veronesi U, et al. Among authors: decensi a.
Ann Oncol. 2006 Jul;17(7):1065-71. doi: 10.1093/annonc/mdl047. Epub 2006 May 4.
Ann Oncol. 2006.
PMID: 16675486
Free article.
Clinical Trial.